Skip to main content

01.12.2015 | Debate | Ausgabe 1/2015 Open Access

BMC Public Health 1/2015

Restricted access to antiretroviral treatment for undocumented migrants: a bottle neck to control the HIV epidemic in the EU/EEA

BMC Public Health > Ausgabe 1/2015
Jessika Deblonde, André Sasse, Julia Del Amo, Fiona Burns, Valerie Delpech, Susan Cowan, Michele Levoy, Lilana Keith, Anastasia Pharris, Andrew Amato-Gauci, Teymur Noori
Wichtige Hinweise

Competing interests

No competing interests to declare.

Authors’ contributions

The outline of the debate was designed by JD, AS and TN. Epidemiological data on HIV among migrants in Europe were provided and interpreted by AP, AS and JDA. Literature from policy reports and the PubMed database was selected and analysed by JD. The review of national policies regarding ART treatment for undocumented migrants was provided by TN. The manuscript was drafted by JD and AS. All co-authors read and critically revised the subsequent drafts of the manuscript and approved the final version.



In the European Union/European Economic Area (EU/EEA), migrants from high-endemic countries are disproportionately affected by HIV. Between 2007 and 2012, migrants represented 39 % of reported HIV cases. There is growing evidence that a significant proportion of HIV acquisition among migrant populations occurs after their arrival in Europe.


Migrants are confronted with multiple risk factors that shape patterns of population HIV susceptibility and vulnerability, which simultaneously affect HIV transmission. Undocumented migrants incur additional risks for contracting HIV due to limited access to adequate health care services, protection and justice, alongside insecure housing and employment conditions.
All EU/EEA countries have ratified a number of international and regional human rights instruments that enshrine access to health care as a human right that should be available to everyone without discrimination.
From a clinical and public health perspective, early HIV care and treatment is associated with viral suppression, improved health outcomes and reductions in transmission risks. A current challenge of the HIV epidemic is to reach the highest proportion of overall viral suppression among people living with HIV in order to impact on HIV transmission.
Although the majority of EU/EEA countries regard migrants as an important sub-population for their national responses to HIV, and despite the overwhelming evidence of the individual and public health benefits associated with HIV care and treatment, a significant number of EU/EEA countries do not provide antiretroviral treatment to undocumented migrants.


HIV transmission dynamics in migrant populations depend on the respective weight of all risk and vulnerability factors to which they are exposed, which act together in a synergistic way. People who are not linked to HIV care will continue to unwillingly contribute to the on-going transmission of HIV. Following the recommendations of the European Union Agency for Fundamental Rights, ensuring access to HIV-care for all sub-populations, including undocumented migrants, would fulfil the human rights of those populations and also strengthen the control of HIV incidence among those not currently able to access HIV care.
Über diesen Artikel

Weitere Artikel der Ausgabe 1/2015

BMC Public Health 1/2015 Zur Ausgabe